로딩 중…
지수 로딩 중…
Design Therapeutics, Inc.
DSGN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$12.44+4.27%
2026-06-18
Price Chart
Design Therapeutics, Inc.+228.23%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $777M |
| Revenue | $0.00 |
| Net Income | $-70M |
| Total Assets | $230M |
| Net Assets | $218M |
| Value | |
| P/B | 3.56x |
| FCF Yield | -6.97% |
| Profitability | |
| ROE | -31.97% |
| ROA | -30.25% |
| Financial Health | |
| Debt Ratio | 5.68% |
| Total Debt | $3M |
| FCF | $-54M |
| Cash | $13M |
| Current Ratio | 22.28x |
| Performance | |
| 1Y Return | 228.23% |
| 1M Return | 18.59% |
| From 52W High | -27.88% |
| 1Y MDD | -35.59% |
| Trading | |
| Volume | 925,827 shares |
| Trading Value | $11M |
| Per Share | |
| EPS | $-1.22 |
| BPS | $3.71 |